Bank of New Hampshire’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.2K Hold
782
0.01% 309
2026
Q1
$67.8K Hold
782
0.02% 290
2025
Q4
$75.1K Sell
782
-1,205
-61% -$117K 0.02% 257
2025
Q3
$189K Hold
1,987
0.04% 191
2025
Q2
$173K Hold
1,987
0.04% 200
2025
Q1
$179K Hold
1,987
0.05% 193
2024
Q4
$159K Hold
1,987
0.04% 198
2024
Q3
$179K Hold
1,987
0.04% 198
2024
Q2
$156K Hold
1,987
0.04% 205
2024
Q1
$173K Hold
1,987
0.05% 205
2023
Q4
$164K Sell
1,987
-410
-17% -$31.2K 0.05% 209
2023
Q3
$188K Hold
2,397
0.06% 191
2023
Q2
$211K Sell
2,397
-110
-4% -$9.47K 0.06% 188
2023
Q1
$202K Hold
2,507
0.06% 188
2022
Q4
$195K Hold
2,507
0.06% 184
2022
Q3
$202K Buy
2,507
+7
+0.3% +$629 0.06% 186
2022
Q2
$224K Sell
2,500
-42
-2% -$4.26K 0.06% 184
2022
Q1
$282K Buy
2,542
+42
+2% +$4.44K 0.07% 178
2021
Q4
$259K Sell
2,500
-400
-14% -$46.3K 0.06% 184
2021
Q3
$360K Hold
2,900
0.1% 156
2021
Q2
$360K Buy
+2,900
New +$364K 0.1% 156

Other funds holding MDT

Bank of New Hampshire's MDT Position: Q2 2026 in Review

Bank of New Hampshire held its Medtronic (MDT) position steady in Q2 2026 at 782 shares worth $61.2K. The position accounts for 0.01% of the portfolio, ranked #309.

Bank of New Hampshire first reported a position in MDT in Q2 2021 and has held it in 21 quarters since. The position peaked at $360K in Q3 2021. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bank of New Hampshire held 782 shares of Medtronic worth $61.2K as of Q2 2026.
  • Bank of New Hampshire left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #309 holding.
  • Bank of New Hampshire first reported a position in Medtronic in Q2 2021 and has held it in 21 quarters since.
  • Bank of New Hampshire's Medtronic position peaked at $360K in Q3 2021.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.